View More Recent Stories

Jan 22, 2020 07:00AM Nevro to Present New Clinical Evidence at the 23rd Annual North American Neuromodulation (NANS) Society Meeting
Jan 20, 2020 07:00AM Nevro Names Donald A. Middlebrook to Lead Clinical, Regulatory and Quality
Jan 14, 2020 07:05AM Nevro (NVRO) Reports Prelim. Q$ & FY19 Revenues Results Above Consensus; Provides FY20 Revenue Guidance Above Consensus
Jan 14, 2020 07:00AM Nevro Announces Preliminary Unaudited Fourth Quarter and Full Year 2019 Revenue
Jan 10, 2020 07:00AM Nevro to Host Investor Briefing at North American Neuromodulation Society (NANS) 2020 Conference
Dec 19, 2019 07:00AM Nevro to Present at the 38th Annual J.P. Morgan Healthcare Conference
Dec 18, 2019 07:00AM ­Nevro Appoints Karen N. Prange to the Company's Board of Directors
Nov 6, 2019 04:10PM Nevro Reports Third Quarter 2019 Financial Results
Nov 5, 2019 07:00AM Nevro Announces U.S. Launch of Senza® Omnia™ Spinal Cord Stimulation System to Treat Chronic Pain
Jul 16, 2015 11:52AM Austin Pain Associates Offers Innovative New FDA Approved Therapy for Back and Leg Pain
View More Recent Stories